These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 18565401)

  • 1. Markers of activated coagulation in acute coronary syndromes.
    Goetze JP
    J Am Coll Cardiol; 2008 Jun; 51(25):2430-1. PubMed ID: 18565401
    [No Abstract]   [Full Text] [Related]  

  • 2. HDL-cholesterol level provides additional prognosis in acute coronary syndromes.
    Correia LC; Rocha MS; Esteves JP
    Int J Cardiol; 2009 Aug; 136(3):307-14. PubMed ID: 18706714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic utility of D-dimer and fibrin monomer at long-term follow-up after hospitalization with coronary chest pain.
    Brügger-Andersen T; Pönitz V; Staines H; Grundt H; Hetland Ø; Nilsen DW
    Blood Coagul Fibrinolysis; 2008 Oct; 19(7):701-7. PubMed ID: 18832914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pro-inflammatory and anti-inflammatory markers in coronary artery disease and acute ischemic coronary syndrome].
    Fragoso-Lona JM; Ramírez-Bello J; Cruz-Robles D; Pérez-Méndez O; de la Peña A; Vargas-Alarcón G
    Arch Cardiol Mex; 2009; 79(1):54-62. PubMed ID: 19545076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential role of natriuretic peptides in acute coronary syndrome stratification.
    Beltrami M; Nuti R; Gilleman M; Palazzuoli A
    Future Cardiol; 2013 May; 9(3):297-300. PubMed ID: 23668732
    [No Abstract]   [Full Text] [Related]  

  • 6. Ischaemia modified albumin in the diagnosis of acute coronary syndromes.
    Pantazopoulos I; Papadimitriou L; Dontas I; Demestiha T; Iakovidou N; Xanthos T
    Resuscitation; 2009 Mar; 80(3):306-10. PubMed ID: 19111377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers for prognostication after acute coronary syndromes: new times and statistics.
    deFilippi CR; Seliger SL
    J Am Coll Cardiol; 2009 Jul; 54(4):365-7. PubMed ID: 19608035
    [No Abstract]   [Full Text] [Related]  

  • 8. Soluble tissue factor and tissue factor pathway inhibitor in cardiovascular disease.
    Toschi V
    J Thromb Haemost; 2007 Mar; 5(3):472-4. PubMed ID: 17319902
    [No Abstract]   [Full Text] [Related]  

  • 9. Endogenous thrombolysis: a hidden player in acute coronary syndromes?
    Barrabés JA; Galian L
    J Am Coll Cardiol; 2010 May; 55(19):2116-7. PubMed ID: 20447534
    [No Abstract]   [Full Text] [Related]  

  • 10. The clinical dilemma of positive results of high-sensitive troponin assays.
    Lippi G; Montagnana M; Guidi GC
    Am J Cardiol; 2009 May; 103(9):1332. PubMed ID: 19406287
    [No Abstract]   [Full Text] [Related]  

  • 11. Current status of activation markers in ischemic heart disease: markers of coagulation activation.
    Merlini PA; Ardissino D
    Thromb Haemost; 1997 Jul; 78(1):276-9. PubMed ID: 9198166
    [No Abstract]   [Full Text] [Related]  

  • 12. Tailor-made therapy for the prevention of acute coronary syndromes: future role of biomarkers in risk stratification and disease management.
    Oemrawsingh RM; Akkerhuis KM; Boersma E
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):435-7. PubMed ID: 18402533
    [No Abstract]   [Full Text] [Related]  

  • 13. Highly sensitive troponins the answer or just more questions?
    Hollander JE
    J Am Coll Cardiol; 2009 Sep; 54(13):1173-5. PubMed ID: 19761939
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk stratification in non-ST-segment elevation acute coronary syndromes: troponin alone is not enough.
    Steg PG; FitzGerald G; Fox KA
    Am J Med; 2009 Feb; 122(2):107-8. PubMed ID: 19185082
    [No Abstract]   [Full Text] [Related]  

  • 15. [Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes].
    Bassand JP; Hamm CW; Ardissino D; Boersma E; Budaj A; Fernandez-Aviles F; Fox KA; Hasdai D; Ohman EM; Wallentin L; Wijns W;
    Rev Port Cardiol; 2008 Sep; 27(9):1063-143. PubMed ID: 19044176
    [No Abstract]   [Full Text] [Related]  

  • 16. Leptin in acute coronary syndromes: has the time come for its use in risk stratification?
    Amasyali B; Kose S; Kursaklioglu H; Kilic A; Isik E
    Int J Cardiol; 2008 Nov; 130(2):264-5. PubMed ID: 17669522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Will SCUBE1 solve the ischemia marker deficit?
    Peacock WF
    J Am Coll Cardiol; 2008 Jun; 51(22):2181-3. PubMed ID: 18510967
    [No Abstract]   [Full Text] [Related]  

  • 18. European Resuscitation Council Guidelines for Resuscitation 2010 Section 5. Initial management of acute coronary syndromes.
    Arntz HR; Bossaert LL; Danchin N; Nikolaou NI
    Resuscitation; 2010 Oct; 81(10):1353-63. PubMed ID: 20956048
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis of N-terminal pro-B-type natriuretic peptide in patients with acute coronary syndromes.
    Coppola G; Corrado E; Mulè MC; Augugliaro S; Cucchiara A; Novo G; Amoroso G; Assennato P; Hoffmann E; Vitale F; Novo S
    Coron Artery Dis; 2009 May; 20(3):225-9. PubMed ID: 19387249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The skinny on fatty acid-binding protein.
    de Lemos JA; O'Donoghue M
    J Am Coll Cardiol; 2007 Nov; 50(21):2068-70. PubMed ID: 18021875
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.